In the research studies conducted for the analysis and classification of breast tumors, DNA microassays and gene expression patterns are primarily used. Breast tumors are divided into different groups with these methods. Gene expression-based classifications are known to have important effects on survival and prognosis. Breast cancer is a heterogeneous disease comprised of different histologic subtypes. This heterogeneity results in different clinical presentations and carries different underlying molecular markers. Determining the classification of the tumor based on genomic as well as phenotypic variability will provide important information about the course of the disease and facilitate determining the most relevant therapy model. In thi...
Breast cancer is a heterogeneous disease. The traditional classification uses morphology to divide t...
Molecular classification has added important knowledge to breast cancer biology, but has yet to be i...
Advances in molecular biology had changed approaches to systemic treatment of breast cancer. Clinica...
At present, the biology of breast cancer remains poorly understood. Currently, lymph node metastases...
Morphologically identical breast cancers can display divergent clinical outcomes and responses to th...
Breast cancer is a complex, multifaceted disease encompassing a great variety of entities that show ...
International audienceABSTRACT Breast cancer is the most frequent and the most deadly cancer in wome...
Breast cancer is a heterogeneous disease featuring distinct histological, molecular and clinical phe...
International audienceThe current histoclinical breast cancer classification is simple but imprecise...
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular...
It is now accepted that breast cancer is not a single disease, but instead it is composed of a spect...
Understanding genetic mechanisms and detection of biological markers of tumor growth forms an indivi...
Breast cancer is a complex disease, with heterogeneous presentations and clinical courses. Standard ...
Abstract Molecular classification has added important knowledge to breast cancer biology, but has ye...
Breast cancer complexity has long been known and investigated. After a first classification of the d...
Breast cancer is a heterogeneous disease. The traditional classification uses morphology to divide t...
Molecular classification has added important knowledge to breast cancer biology, but has yet to be i...
Advances in molecular biology had changed approaches to systemic treatment of breast cancer. Clinica...
At present, the biology of breast cancer remains poorly understood. Currently, lymph node metastases...
Morphologically identical breast cancers can display divergent clinical outcomes and responses to th...
Breast cancer is a complex, multifaceted disease encompassing a great variety of entities that show ...
International audienceABSTRACT Breast cancer is the most frequent and the most deadly cancer in wome...
Breast cancer is a heterogeneous disease featuring distinct histological, molecular and clinical phe...
International audienceThe current histoclinical breast cancer classification is simple but imprecise...
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular...
It is now accepted that breast cancer is not a single disease, but instead it is composed of a spect...
Understanding genetic mechanisms and detection of biological markers of tumor growth forms an indivi...
Breast cancer is a complex disease, with heterogeneous presentations and clinical courses. Standard ...
Abstract Molecular classification has added important knowledge to breast cancer biology, but has ye...
Breast cancer complexity has long been known and investigated. After a first classification of the d...
Breast cancer is a heterogeneous disease. The traditional classification uses morphology to divide t...
Molecular classification has added important knowledge to breast cancer biology, but has yet to be i...
Advances in molecular biology had changed approaches to systemic treatment of breast cancer. Clinica...